您的位置: 首页 > 农业专利 > 详情页

Liquid nasal spray containing low-dose naltrexone
专利权人:
L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA’ DI ESERCIZIO S.p.A.
发明人:
Angeli Roberto,Raffaeli William,Rigamonti Maria Adele
申请号:
NZ60441711
公开号:
NZ604417A
申请日:
2011.05.20
申请国别(地区):
NZ
年份:
2014
代理人:
摘要:
ABSTRACT - 604417 The disclosure relates to a spray formulation for administration of opioid antagonists at low concentrations by the nasal route for reducing the adverse side-effects of opioids such as morphine, particularly in oncologic patients receiving therapy, wherein the formulation comprises one of the following compositions: (1) Hydroxypropyl methylcellulose 0.2%w/v Benzalkonium chloride 0.02%w/v Anhydrous citric acid 0.14%w/v Sodium citrate dihydrate 0.37%w/v Sodium chloride 0.72% w/v Naltrexone hydrochloride 0.010%w/v; (2) Hydroxypropyl methylcellulose 0.2%w/v Sodium propyl parahydroxybenzoate 0.02%w/v Anhydrous citric acid 0.14%w/v Sodium citrate dihydrate 0.37%w/v Sodium chloride 0.72% w/v Naltrexone hydrochloride 0.010%w/v; or (3) Methylcellulose 0.5%w/v Benzalkonium chloride 0.02%w/v Anhydrous citric acid 0.14%w/v Sodium citrate dihydrate 0.37%w/v Sodium chloride 0.72% w/v Naltrexone hydrochloride 0.010%w/v
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充